Ginkgo Bioworks (NYSE:DNA) just reported first quarter results for 2023.
- Ginkgo Bioworks reported a loss per share of 11 cents. This was worse than the analyst estimate for a loss of 9 cents.
- The company reported revenue of $80.7 million.
- This came in higher than the analyst estimate for revenue of $71.68 million.
- You can read the full Ginkgo Bioworks press release here.
On the date of publication, Sarah Smith did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
Sarah Smith is the Editor-in-Chief of InvestorPlace.com.